Results 201 to 210 of about 76,175 (312)

Prevalence of vector‐borne pathogens Ehrlichia canis, Babesia spp. and Dirofilaria immitis in dogs in Townsville, far north Queensland

open access: yesAustralian Veterinary Journal, EarlyView.
Ehrlichia canis, Babesia spp. and Dirofilaria immitis are blood‐borne pathogens transmitted to dogs by arthropods. The aim of the current study was to investigate the prevalence of E. canis, Babesia spp. and D. immitis in domestic dogs, aged 6 months or older, in Townsville, in far north Queensland, Australia.
K Gerber   +5 more
wiley   +1 more source

Species of Cryptosporidia Causing Subclinical Infection Associated With Growth Faltering in Rural and Urban Bangladesh: A Birth Cohort Study. [PDF]

open access: yesClin Infect Dis, 2018
Steiner KL   +14 more
europepmc   +1 more source

Evaluation of Serological and Virological Tests in the Diagnosis of Clinical and Subclinical Measles Virus Infections during an Outbreak of Measles in The Netherlands

open access: bronze, 2003
Robert S. van Binnendijk   +7 more
openalex   +1 more source

Anti‐thymocyte globulin in immune‐mediated cytopenias: A monocentric experience and literature review

open access: yesBritish Journal of Haematology, EarlyView.
Anti‐thymocyte globulin in multi‐refractory immune‐mediated cytopenia is an effective treatment, with response rate as high as 65%. Younger patients, presenting with thrombocytopenia or neutropenia, and those with LGL and STAT3 mutations appear to be more likely responsive.
Luca Guarnera   +12 more
wiley   +1 more source

Use of Antibodies in Lymphocyte Secretions for Detection of Subclinical Tuberculosis Infection in Asymptomatic Contacts

open access: gold, 2004
Rubhana Raqib   +11 more
openalex   +1 more source

Salmonella entericaSubclinical Infection: Bacteriological, Serological, Pulsed-Field Gel Electrophoresis, and Antimicrobial Resistance Profiles—Longitudinal Study in a Three-Site Farrow-to-Finish Farm [PDF]

open access: green, 2009
Germán B. Vigo   +12 more
openalex   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen   +3 more
wiley   +1 more source

The DCIDE framework: systematic investigation of evolutionary hypotheses, exemplified with autism

open access: yesBiological Reviews, EarlyView.
ABSTRACT Evolutionary explanations of mental disorders are a longstanding aim of evolutionary psychiatry, but have suffered from complexities including within‐disorder heterogeneity and environmental effects of contemporary societies obscuring possible ancestral functions.
Adam D. Hunt, Adrian V. Jaeggi
wiley   +1 more source

Dynamics and Differences in Systemic and Local Immune Responses After Vaccination With Inactivated and Live Commercial Vaccines and Subsequent Subclinical Infection With PRRS Virus. [PDF]

open access: yesFront Immunol, 2019
Toman M   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy